Israel's Enlivex reports drug could help COVID-19 patients

Amazing stuff! A sepsis treatment for severe coronavirus patients!

Sepsis is a major killer of hospitalized patients. "Each year, at least 1.7 million adults in America develop sepsis. Nearly 270,000 Americans die as a result of sepsis. 1 in 3 patients who die in a hospital have sepsis." (CDC)

"Hyperactivity of the immune system, referred to as a cytokine storm or Cytokine Release Syndrome (CRS), is a systemic inflammatory response in which cytokine release spirals out of control, leading to severe immune attacks on multiple healthy organs, which may result in organ damage, multiple organ failure, and mortality
A cytokine storm can be triggered by factors such as viral, bacterial and fungal infections, i.e. sepsis – as well as by complications following bone-marrow transplantations, i.e., GvHD. 
Allocetra is an innovative immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system’s own natural regulation mechanisms. By intelligently engaging macrophages and dendritic cells, Allocetra is designed to avert cytokine storms and restore safe immune balance – without suppressing the immune system."

Israel's Enlivex reports drug could help COVID-19 patients - Globes: Enlivex Therapeutics is increasing production of Allocetra, for treating patients with multisystem failure.

Here is the company link to this new medication Allocetra:
https://www.enlivex.com/allocetra/